Suspected Cervical Cancer

This patient should be suspected to have cervical cancer until proven otherwise, due to inflammation of the cervix that has been shown to be non-infective and no documented smear history, which puts her at higher risk. Empirical treatment for Chlamydia or gonorrhoea would not usually be suggested in general practice unless the patient has symptoms and signs of PID. Referring to an STD clinic is incorrect, as urgent investigation for cancer is necessary. Referring routinely to gynaecology is an option, but it doesn’t fully take into account the urgency of ruling out cervical cancer. Arranging a smear test for a lady with suspected cervical cancer would be inappropriate, as smear tests do not diagnose cancer, they only assess the likelihood of cancer occurring in the future.

If a woman has a history of STI, it is advisable to refer her to secondary care earlier. For women under 36 years of age, referral for further assessment and management should be considered if they have not conceived after one year, and their history, examination, and investigations are normal. However, if the woman is 36 years or older, has amenorrhea or oligomenorrhea, previous abdominal or pelvic surgery, previous pelvic inflammatory disease, abnormal pelvic examination, or a known reason for infertility, earlier referral should be considered. Similarly, for men, referral should be considered earlier if they have a history of previous genital pathology, urogenital surgery, STI, varicocele, significant systemic illness, abnormal genital examination, or a known reason for infertility.

Understanding Infertility: Initial Investigations and Key Counselling Points

Infertility is a common issue that affects approximately 1 in 7 couples. However, it is important to note that around 84% of couples who have regular sex will conceive within 1 year, and 92% within 2 years. The causes of infertility can vary, with male factor accounting for 30%, unexplained causes accounting for 20%, ovulation failure accounting for 20%, tubal damage accounting for 15%, and other causes accounting for the remaining 15%.

To determine the cause of infertility, basic investigations are typically conducted. These include a semen analysis and a serum progesterone test, which is done 7 days prior to the expected next period. The interpretation of the serum progesterone level is as follows: if the level is less than 16 nmol/l, it should be repeated and if it consistently remains low, referral to a specialist is necessary. If the level is between 16-30 nmol/l, it should be repeated, and if it is greater than 30 nmol/l, it indicates ovulation.

In addition to these investigations, there are key counselling points that should be addressed. These include advising the patient to take folic acid, aiming for a BMI between 20-25, and having regular sexual intercourse every 2 to 3 days. Patients should also be advised to quit smoking and limit alcohol consumption.

By understanding the initial investigations and key counselling points for infertility, healthcare professionals can provide their patients with the necessary information and support to help them conceive.

Understanding Gonorrhoea

Gonorrhoea is a sexually transmitted infection caused by Neisseria gonorrhoeae. It is characterized by purulent urethral discharge and epididymitis. To diagnose gonorrhoea, a Gram stain of the urethral discharge fluid is performed. It is important to trace partners where possible to prevent further spread of the infection.

The treatment of choice for gonorrhoea is Ceftriaxone IM due to increased resistance to fluoroquinolones. Azithromycin 1G orally as a single dose is also recommended. Other combinations are available as alternatives. It is crucial to screen the patient for other sexually transmitted infections, including HIV.

In summary, gonorrhoea is a common sexually transmitted infection that can be easily diagnosed and treated. Early detection and treatment are essential to prevent complications and further spread of the infection.

If alginates/thickened feeds fail to alleviate symptoms in infants with GORD and they exhibit feeding difficulties, distressed behavior, or faltering growth, a trial of PPI is recommended by NICE. However, metoclopramide should not be used without specialist advice due to the risk of side-effects like dystonia. Restarting breastfeeding is not practical once it has stopped, and there is no evidence to suggest that it would improve symptoms. While cow’s milk protein intolerance should be considered as a differential diagnosis, there is currently no indication of this diagnosis. Additionally, it is not advisable to stop milk feeds for such a young baby.

Gastro-oesophageal reflux is a common cause of vomiting in infants, with around 40% of babies experiencing some degree of regurgitation. However, certain risk factors such as preterm delivery and neurological disorders can increase the likelihood of developing this condition. Symptoms typically appear before 8 weeks of age and include vomiting or regurgitation, milky vomits after feeds, and excessive crying during feeding. Diagnosis is usually made based on clinical observation.

Management of gastro-oesophageal reflux in infants involves advising parents on proper feeding positions, ensuring the infant is not overfed, and considering a trial of thickened formula or alginate therapy. However, proton pump inhibitors (PPIs) are not recommended as a first-line treatment for isolated symptoms of regurgitation. PPIs may be considered if the infant experiences unexplained feeding difficulties, distressed behavior, or faltering growth. Metoclopramide, a prokinetic agent, should only be used with specialist advice.

Complications of gastro-oesophageal reflux can include distress, failure to thrive, aspiration, frequent otitis media, and dental erosion in older children. If medical treatment is ineffective and severe complications arise, fundoplication may be considered. It is important for healthcare professionals to be aware of the risk factors, symptoms, and management options for gastro-oesophageal reflux in infants.

Causes and Characteristics of Unilateral Ptosis and Lid Lag in Thyrotoxicosis

Unilateral ptosis, or drooping of one eyelid, can be caused by disinsertion of the aponeurosis of the levator palpabrae superioris, Horner syndrome, or a third nerve palsy. Local inflammation of the conjunctiva can also lead to ptosis. Myasthenia gravis typically results in bilateral ptosis, but it may be asymmetrical.

Disinsertion of the aponeurosis of the levator palpabrae superioris is characterized by the loss of the crease normally seen on the upper eyelid and is often due to dysfunction of the superior rectus and levator muscles. It may be iatrogenic or degenerative due to senility.

Lid lag, where the upper eyelid lags behind the upper edge of the iris as the eye moves downward, is a common characteristic of thyrotoxicosis. A similar phenomenon can occur with the lower edge when the eye moves upwards.

In cases where weakness of hand muscles is present, a T1 root lesion is likely, indicating Horner syndrome. Miosis, or constriction of the pupil, can be subtle and easily missed. In smokers, a high suspicion of a Pancoast’s tumor (apical pulmonary tumor) should be considered in patients with such a presentation.

Managing Resistant Hypertension

Resistant hypertension can be a challenging condition to manage, often requiring up to four different Antihypertensive agents. If a person is already taking three Antihypertensive drugs and their blood pressure is still not controlled, increasing chlorthalidone to a maximum of 50 mg may be considered, provided that blood potassium levels are higher than 4.5mmol/L. However, caution should be exercised when using co-amilofruse, a potassium-sparing diuretic, in conjunction with valsartan, especially if the patient has a recent history of having a potassium level of 4.5 or higher.

If a patient has previously developed a cough with an ACE inhibitor, switching to a different ACE inhibitor is unlikely to make any difference. In such cases, bisoprolol may be added if further diuretic treatment is not tolerated, is contraindicated, or is ineffective. It is important to seek specialist advice if secondary causes for hypertension are likely or if a patient’s blood pressure is not controlled on the optimal or maximum tolerated doses of four Antihypertensive drugs.

Consider diabetes insipidus as the possible diagnosis for a patient presenting with polyuria and polydipsia, along with low potassium levels and no evidence of diabetes mellitus. The patient being a boxer may suggest head trauma, which is one of the potential causes of cranial diabetes insipidus. In this condition, urine cannot be effectively concentrated due to damage to the cranial source of ADH. Nephrogenic diabetes insipidus, on the other hand, occurs when the kidneys do not respond to ADH appropriately.

Addison’s disease is less likely as it would not cause increased urination, and the patient would try to preserve water to compensate for dehydration. Additionally, Addison’s disease would cause elevated potassium levels and is unlikely without abdominal pain, nausea, or vomiting.

Cushing’s disease is not the most likely diagnosis as the patient doesn’t present with the classical signs and symptoms such as central obesity, moon face, buffalo hump, psychological problems, and glucose intolerance.

Type I diabetes is unlikely as there is no glucose in the urine and normal glucose on VBG. Onset of type I diabetes at the age of 42 is also uncommon.

Diabetes insipidus is a medical condition that can be caused by either a decreased secretion of antidiuretic hormone (ADH) from the pituitary gland (cranial DI) or an insensitivity to ADH (nephrogenic DI). Cranial DI can be caused by various factors such as head injury, pituitary surgery, and infiltrative diseases like sarcoidosis. On the other hand, nephrogenic DI can be caused by genetic factors, electrolyte imbalances, and certain medications like lithium and demeclocycline. The common symptoms of DI are excessive urination and thirst. Diagnosis is made through a water deprivation test and checking the osmolality of the urine. Treatment options include thiazides and a low salt/protein diet for nephrogenic DI, while central DI can be treated with desmopressin.

Pregnant women are advised to avoid all pharmacological migraine prophylactics, but topiramate is particularly linked to foetal malformations. Women who take topiramate and are of reproductive age should use a reliable long-term contraception method. Although topiramate is also used to treat epilepsy, its use during pregnancy should be carefully monitored by a neurologist and an obstetrician. Propranolol and amitriptyline are licensed as migraine prophylactics, but their use during pregnancy should only be considered under the guidance of a neurologist. Acupuncture is recommended in the NICE guidelines for migraine as an alternative for women who cannot use pharmacological prophylaxis, but it is not generally available on the NHS.

Topiramate: Mechanisms of Action and Contraceptive Considerations

Topiramate is a medication primarily used to treat seizures. It can be used alone or in combination with other drugs. The drug has multiple mechanisms of action, including blocking voltage-gated Na+ channels, increasing GABA action, and inhibiting carbonic anhydrase. The latter effect results in a decrease in urinary citrate excretion and the formation of alkaline urine, which favors the creation of calcium phosphate stones.

Topiramate is known to induce the P450 enzyme CYP3A4, which can reduce the effectiveness of hormonal contraception. Therefore, the Faculty of Sexual and Reproductive Health (FSRH) recommends that patients taking topiramate consider alternative forms of contraception. For example, the combined oral contraceptive pill and progestogen-only pill are not recommended, while the implant is generally considered safe.

Topiramate can cause several side effects, including reduced appetite and weight loss, dizziness, paraesthesia, lethargy, and poor concentration. However, the most significant risk associated with topiramate is the potential for fetal malformations. Additionally, rare but important side effects include acute myopia and secondary angle-closure glaucoma. Overall, topiramate is a useful medication for treating seizures, but patients should be aware of its potential side effects and contraceptive considerations.

Understanding Oral Allergy Syndrome

Oral allergy syndrome, also known as pollen-food allergy, is a type of hypersensitivity reaction that occurs when a person with a pollen allergy eats certain raw, plant-based foods. This reaction is caused by cross-reaction with a non-food allergen, most commonly birch pollen, where the protein in the food is similar but not identical in structure to the original allergen. As a result, OAS is strongly linked with pollen allergies and presents with seasonal variation. Symptoms of OAS typically include mild tingling or itching of the lips, tongue, and mouth.

It is important to note that OAS is different from food allergies, which are caused by direct sensitivity to a protein present in food. Non-plant foods do not cause OAS because there are no cross-reactive allergens in pollen that would be structurally similar to meat. Food allergies may be caused by plant or non-plant foods and can lead to systemic symptoms such as vomiting and diarrhea, and even anaphylaxis.

OAS is a clinical diagnosis, but further tests can be used to rule out other diagnoses and confirm the diagnosis when the history is unclear. Treatment for OAS involves avoiding the culprit foods and taking oral antihistamines if symptoms develop. In severe cases, an ambulance should be called, and intramuscular adrenaline may be required.

In conclusion, understanding oral allergy syndrome is important for individuals with pollen allergies who may experience symptoms after eating certain raw, plant-based foods. By avoiding the culprit foods and seeking appropriate medical care when necessary, individuals with OAS can manage their symptoms effectively.

The initial treatment for urge incontinence is bladder retraining, while pelvic floor muscle training is the first-line approach for stress incontinence. Toileting aids alone are not effective in resolving urge incontinence and should not be recommended as the primary treatment. Oxybutynin and botulin injections may be considered as secondary treatment options if necessary.

Urinary incontinence is a common condition that affects approximately 4-5% of the population, with elderly females being more susceptible. There are several risk factors that can contribute to the development of urinary incontinence, including advancing age, previous pregnancy and childbirth, high body mass index, hysterectomy, and family history. The condition can be classified into different types, such as overactive bladder, stress incontinence, mixed incontinence, overflow incontinence, and functional incontinence.

Initial investigation of urinary incontinence involves completing bladder diaries for at least three days, performing a vaginal examination to exclude pelvic organ prolapse, and conducting urine dipstick and culture tests. Urodynamic studies may also be necessary. Management of urinary incontinence depends on the predominant type of incontinence. For urge incontinence, bladder retraining and bladder stabilizing drugs such as antimuscarinics are recommended. For stress incontinence, pelvic floor muscle training and surgical procedures may be necessary. Duloxetine, a combined noradrenaline and serotonin reuptake inhibitor, may also be offered to women who decline surgical procedures.

In summary, urinary incontinence is a common condition that can be caused by various risk factors. It can be classified into different types, and management depends on the predominant type of incontinence. Initial investigation involves completing bladder diaries, performing a vaginal examination, and conducting urine tests. Treatment options include bladder retraining, bladder stabilizing drugs, pelvic floor muscle training, surgical procedures, and duloxetine.

Slipped Epiphysis: Diagnosis and Treatment

Slipped epiphysis is a condition commonly found in overweight boys aged 10-15, with an association with obesity and hypothyroidism. Patients often present with pain, which may be referred to the knee, and a thorough examination of the hips is necessary. Key findings supporting the diagnosis include risk factors, leg shortening, and reduced internal rotation.

The condition can be classified based on chronicity and stability. Acute, chronic, and acute on chronic are the classifications based on chronicity, while unstable and stable are the classifications based on stability. X-ray is the first line investigation for chronic and stable slipped epiphysis, and other tests such as U&Es, serum TFTs, and serum growth hormone may also be considered.

Bilateral antero-posterior x-rays are performed, and Klein’s line is drawn along the superior aspect of the femoral neck to intersect the femoral head in a healthy hip. With slipped epiphysis, Klein’s line doesn’t intersect the femoral head. A frog leg lateral x-ray is a more sensitive view, where the physis may also be blurred or widened, known as Bloomberg’s sign.

Treatment for unstable slipped epiphysis involves urgent surgical repair due to the risk of avascular necrosis. In contrast, treatment for stable slipped epiphysis usually involves in situ screw fixation. Orthopaedic surgeons may also consider prophylactic fixation of the contralateral hip in both cases.

If a patient on the combined oral contraceptive pill misses two or more pills and has had unprotected sexual intercourse during the pill-free period or week 1 of the pill packet, emergency contraception should be considered. However, if the patient has only missed one pill, like in this case where the patient missed one pill on day 9, emergency contraception is not necessary. A pregnancy test is also not required at this point. However, if the patient had missed two pills and had a history of erratic pill-taking, a pregnancy test would be recommended before prescribing emergency contraception.

If the patient had missed two pills during days 1-7 of the pill packet and had unprotected sex during this time, emergency contraception should be offered. The choice of emergency contraception depends on various factors such as the timing of the unprotected intercourse event, other medications the patient may be taking, and their preferences. EllaOne (ulipristal acetate) can be used up to 120 hours after unprotected intercourse, while Levonelle (levonorgestrel) can be used up to 96 hours after unprotected intercourse.

Offering to insert a copper coil to prevent pregnancy would be inappropriate in this case as emergency contraception is not required. However, if the patient is having trouble remembering to take their pill correctly and wishes to consider a long-acting contraceptive, options such as intrauterine devices, subnormal contraceptive implants, and the contraceptive injection can be discussed. It is important to note that the contraceptive injection cannot be used as a form of emergency contraception.

The Faculty of Sexual and Reproductive Healthcare (FSRH) has updated their advice for women taking a combined oral contraceptive (COC) pill containing 30-35 micrograms of ethinylestradiol. If one pill is missed at any time during the cycle, the woman should take the last pill, even if it means taking two pills in one day, and then continue taking pills daily, one each day. No additional contraceptive protection is needed. However, if two or more pills are missed, the woman should take the last pill, leave any earlier missed pills, and then continue taking pills daily, one each day. She should use condoms or abstain from sex until she has taken pills for seven days in a row. If pills are missed in week one, emergency contraception should be considered if she had unprotected sex in the pill-free interval or in week one. If pills are missed in week two, after seven consecutive days of taking the COC, there is no need for emergency contraception. If pills are missed in week three, she should finish the pills in her current pack and start a new pack the next day, thus omitting the pill-free interval. Theoretically, women would be protected if they took the COC in a pattern of seven days on, seven days off.

Chronic heart failure can be managed through drug therapy, as outlined in the updated guidelines issued by NICE in 2018. While loop diuretics are useful in managing fluid overload, they do not reduce mortality in the long term. The first-line treatment for all patients is an ACE-inhibitor and a beta-blocker, with clinical judgement used to determine which one to start first. Aldosterone antagonists are the standard second-line treatment, but both ACE inhibitors and aldosterone antagonists can cause hyperkalaemia, so potassium levels should be monitored. SGLT-2 inhibitors are increasingly being used to manage heart failure with a reduced ejection fraction, as they reduce glucose reabsorption and increase urinary glucose excretion. Third-line treatment options include ivabradine, sacubitril-valsartan, hydralazine in combination with nitrate, digoxin, and cardiac resynchronisation therapy. Other treatments include annual influenza and one-off pneumococcal vaccines.

According to the NICE guidelines, neuroimaging is necessary for the diagnosis of dementia. Structural imaging, such as magnetic resonance imaging (MRI) or computed tomography (CT) scanning, should be used to rule out other cerebral pathologies and to aid in determining the subtype diagnosis. MRI is preferred for early diagnosis and detecting subcortical vascular changes. However, in cases where the diagnosis is already clear in individuals with moderate to severe dementia, imaging may not be necessary. It is important to seek specialist advice when interpreting scans in individuals with learning disabilities.

Dementia is a condition that affects a significant number of people in the UK, with Alzheimer’s disease being the most common cause followed by vascular and Lewy body dementia. Diagnosis can be challenging and often delayed, but assessment tools such as the 10-point cognitive screener and 6-Item cognitive impairment test are recommended by NICE for non-specialist settings. However, tools like the abbreviated mental test score, General practitioner assessment of cognition, and mini-mental state examination are not recommended. A score of 24 or less out of 30 on the MMSE suggests dementia.

In primary care, a blood screen is usually conducted to exclude reversible causes like hypothyroidism. NICE recommends tests such as FBC, U&E, LFTs, calcium, glucose, ESR/CRP, TFTs, vitamin B12, and folate levels. Patients are often referred to old-age psychiatrists working in memory clinics. In secondary care, neuroimaging is performed to exclude other reversible conditions like subdural haematoma and normal pressure hydrocephalus and provide information on aetiology to guide prognosis and management. The 2011 NICE guidelines state that structural imaging is essential in investigating dementia.

Negative Predictive Value (NPV): The probability that subjects with a negative test result truly do not have the disease.

NPV=True Negatives/(True Negatives+False Negatives)​

Given the data, we have:

• True Negatives (TN): The number of participants with a negative blood test who also had a negative brain imaging result. From the table, this is 895.
• False Negatives (FN): The number of participants with a negative blood test who actually had a positive brain imaging result. From the table, this is 40.

Calculation

Now, substitute the values into the NPV formula:

NPV=895/(895+40)​

Calculate the denominator:

895+40=935

Then calculate the NPV:

NPV=895/935≈0.9575

Convert this to a percentage:

NPV≈95.75%

Conclusion

The negative predictive value (NPV) of the blood test is approximately 95.75%. This means that if an employee tests negative on the blood test, there is a 95.75% chance that they truly do not have Alzheimer’s disease, making the test quite reliable for identifying employees who are free of the disease.

When it comes to children with fevers, healthcare professionals consider appearing unwell to be a red flag. Additionally, not responding appropriately to social cues is an amber flag, as is poor feeding. In children over 12 months old, a respiratory rate exceeding 40 breaths per minute is an amber flag, while a rate over 60 is a red flag. Finally, a heart rate over 150 beats per minute is an amber flag for children between 12 and 24 months old.

The NICE Feverish illness in children guidelines were introduced in 2007 and updated in 2013 to provide a ‘traffic light’ system for assessing the risk of febrile illness in children under 5 years old. The guidelines recommend recording the child’s temperature, heart rate, respiratory rate, and capillary refill time, as well as looking for signs of dehydration. Measuring temperature should be done with an electronic thermometer in the axilla for children under 4 weeks or with an electronic/chemical dot thermometer in the axilla or an infra-red tympanic thermometer. The risk stratification table categorizes children as green (low risk), amber (intermediate risk), or red (high risk) based on their symptoms. Management recommendations vary depending on the risk level, with green children managed at home, amber children provided with a safety net or referred to a specialist, and red children urgently referred to a specialist. The guidelines also advise against prescribing oral antibiotics without an apparent source of fever and note that a chest x-ray is not necessary if a child with suspected pneumonia is not being referred to the hospital.

If a patient or their representative believes that the patient may have a terminal illness, they can request a form DS1500 to be issued. According to Social Security legislation, a terminal illness is a disease that is advancing and is expected to result in death within six months.

Patients who suffer from chronic illnesses or cancer and require assistance with caring for themselves may be eligible for benefits. Those under the age of 65 can claim Personal Independence Payment (PIP), while those aged 65 and over can claim Attendance Allowance (AA). PIP is tax-free and divided into two components: daily living and mobility. Patients must have a long-term health condition or disability and have difficulties with activities related to daily living and/or mobility for at least 3 months, with an expectation that these difficulties will last for at least 9 months. AA is also tax-free and is for those who need help with personal care. Patients should have needed help for at least 6 months to claim AA.

Patients who have a terminal illness and are not expected to live for more than 6 months can be fast-tracked through the system for claiming incapacity benefit (IB), employment support allowance (ESA), DLA or AA. A DS1500 form is completed by a hospital or hospice consultant, which contains questions about the diagnosis, clinical features, treatment, and whether the patient is aware of the condition/prognosis. The form is given directly to the patient and a fee is payable by the Department for Works and Pensions (DWP) for its completion. This ensures that the application is dealt with promptly and that the patient automatically receives the higher rate.

Timing and Options for Emergency Contraception

When it comes to emergency contraception, timing is crucial. If ovulation can be estimated, an IUD can be inserted up to five days after the expected date of ovulation. On the other hand, levonorgestrel can be taken beyond the recommended 72-hour window, but its effectiveness may be reduced. It can also be repeated within the same menstrual cycle. In cases where condoms are the only form of contraception, additional levonorgestrel may be prescribed. However, it’s important to note that pharmacists will not sell levonorgestrel to males. By understanding the timing and options for emergency contraception, individuals can make informed decisions about their reproductive health.

Infections after Renal Transplantation: Common Types and Risks

Renal transplant patients are at high risk of infections, with over 50% experiencing at least one infection in the first year. In the first month, the risk is similar to that of non-immunosuppressed individuals, with common infections such as postoperative pneumonias and wound infections. However, in the one to six-month period, immunomodulating viruses like Cytomegalovirus (CMV), herpes simplex viruses, Epstein–Barr virus, and human herpesvirus-6 become more problematic.

Herpes simplex virus can cause severe lesions, including disseminated mucocutaneous disease, oesophagitis, hepatitis, and pneumonitis. influenza can also cause respiratory symptoms, but the injectable inactivated vaccine is safe for kidney transplant recipients. Pneumonia and urinary tract infections are common in the general population, and patients should receive appropriate immunisation.

A small group of patients may experience persistent viral infections, and those who require additional immunosuppression are at risk of opportunistic infections like cryptococcus, pneumocystis, listeria, and nocardia. Urinary infections are the most common after renal transplantation, and patients usually receive prophylactic antibiotics and antiviral drugs for a few months after the procedure.

Statin Therapy for Those with Pre-existing CVD

All individuals with a history of established cardiovascular disease (CVD) should be offered statin therapy, according to NICE guidelines. While diet and lifestyle modifications are important, they should not delay or withhold statin therapy.

For those with pre-existing CVD (excluding chronic kidney disease), atorvastatin 80 mg daily is recommended. However, for individuals with chronic kidney disease and an eGFR of less than 60 mL/min/1.73m2, a lower dose of atorvastatin 20 mg daily is advised. Lower doses may also be considered for those at higher risk of side effects or due to individual preference.

It is not necessary to use the QRISK2 risk assessment tool for those with pre-existing CVD, as they are automatically considered at high risk of CVD and should be treated accordingly. Overall, statin therapy is an important component of managing CVD and should be considered for all individuals with a history of the disease.